CADL
Candel TherapeuticsยทNASDAQ
--
--(--)
--
--(--)
CADL Profile
Candel Therapeutics, Inc.
A late clinical stage biopharmaceutical company that develops novel oncolytic viral immunotherapies
117 Kendrick St Suite 450, Needham, MA 02494
--
Candel Therapeutics, Inc., was incorporated in Delaware in June 2003. The company is a clinical-stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that trigger individualized, systemic anti-tumor immune responses to help patients fight cancer.
